|
|
|||
The inclusion criteria and the 28% prevalence of neurodevelopmental impairment (the pretest probability) indicate that the study patients were already above the accepted risk threshold for follow-up3 and
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |